(Press-News.org) New Rochelle, NY, March 14, 2011—The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yielded a promising near 50% reduction in HIV incidence, but a number of issues require additional research before oral pre-exposure prophylaxis (PrEP) can be implemented on a large scale, according to an article in AIDS Patient Care and STDs, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/apc
After the success of a trial of PrEP in a high risk population of men who have sex with men (MSM), expanded studies are set to begin that will enroll more than 20,000 men and women. Although PrEP comprised of a two-drug regimen (the oral antiretroviral agents tenofovir and emtricitabine) was shown to be safe and effective in early clinical testing, Gavin Myers, MA and Kenneth Mayer, MD, Alpert Medical School of Brown University (Providence, RI) emphasize the need for more research in several key areas: the need for ongoing PrEP clinical monitoring of side effects; the diminished preventive benefits seen in patients who do not adhere to the PrEP regimen and the need for counseling; the attitudes and awareness of physicians who would be prescribing PrEP; and the potential for intermittent PrEP to be as effective as once-daily dosing. They discuss these issues in the article, "Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S. Populations: Current Considerations in Light of New Findings."
"This is an extraordinary example of translational medicine in the service of HIV prevention. But implementation faces major social obstacles. Adherence to a PreP regimen is key. And the cost of the drugs may make it impractical for all but the highest at-risk populations," says Jeffrey Laurence, MD, Editor-in-Chief of the Journal and Director of the Laboratory for AIDS Virus Research at Weill Medical College of Cornell University (New York, NY).
INFORMATION:
AIDS Patient Care and STDs is the leading peer-reviewed journal for clinicians, enabling them to keep pace with the latest developments in this evolving field. Published monthly in print and online that spans the full spectrum of adult and pediatric HIV disease, diagnosis, treatment, prevention, and education. Tables of content and free sample issue may be viewed online at www.liebertpub.com/apc
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Research and Human Retroviruses, Journal of Palliative Medicine, and Viral Immunology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals and books is available at www.liebertpub.com
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
2011-03-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Trapping a rainbow: Lehigh researchers slow broadband light waves with nanoplasmonic structures
2011-03-15
BETHLEHEM, PA—A team of electrical engineers and chemists at Lehigh University have experimentally verified the "rainbow" trapping effect, demonstrating that plasmonic structures can slow down light waves over a broad range of wavelengths.
The idea that a rainbow of broadband light could be slowed down or stopped using plasmonic structures has only recently been predicted in theoretical studies of metamaterials. The Lehigh experiment employed focused ion beams to mill a series of increasingly deeper, nanosized grooves into a thin sheet of silver. By focusing light along ...
Research shows rapid adoption of newer, more expensive prostate cancer treatments
2011-03-15
Boston, MA – With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in the country. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States. New research from the Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) shows that newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002 – 2005 without proof of their cost-effectiveness, and may offer explanations for why health care spending ...
Key mutations act cooperatively to fuel aggressive brain tumor
2011-03-15
Mutations in three pathways important for suppressing tumors cooperate to launch glioblastoma, an aggressive brain tumor that strikes children and adults. But new research from St. Jude Children's Research Hospital scientists shows those changes alone are not sufficient to cause cancer. Tumor formation requires additional mutations, some affecting different points in the same disrupted regulatory pathways.
Researchers demonstrated that in mouse models of glioblastoma, tumors develop in several regions of the brain.
The findings, as well as the technique investigators ...
Why argue? Helping students see the point
2011-03-15
Read the comments on any website and you may despair at Americans' inability to argue well. Thankfully, educators now name argumentive reasoning as one of the basics students should leave school with.
But what are these skills and how do children acquire them? Deanna Kuhn and Amanda Crowell, of Columbia University's Teachers College, have designed an innovative curriculum to foster their development and measured the results. Among their findings, published in Psychological Science, a journal of the Association for Psychological Science, dialogue is a better path to developing ...
Study puts notch on the jagged edge of lung cancer metastasis
2011-03-15
HOUSTON - Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
A team led by scientists at The University of Texas MD Anderson Cancer Center found a way to identify metastasis-prone lung cancer cells and then uncovered a mechanism that shifts primary tumor cells into a more deadly type of cell with the capacity to move elsewhere in the body.
"We think tumors have to learn how to metastasize ...
DU researchers find that headway being made fighting communicable diseases globally
2011-03-15
DENVER – Those working for healthier humans around the globe are making headway in fighting communicable diseases such as AIDS, malaria and diarrheal illness, according to research from the Frederick S. Pardee Center for International Futures in the University of Denver's (DU) Josef Korbel School of International Studies.
The center recently released the third in a series of five volumes that focus on human progress in which researchers explore topics such as education, poverty, infrastructure and governance. The latest book is Improving Global Health: Forecasting the ...
Nanorods developed in UC Riverside lab could greatly improve visual display of information
2011-03-15
VIDEO:
When an external magnetic field is applied to the solution of nanorods, they align themselves parallel to one another like a set of tiny flashlights turned in one direction, and...
Click here for more information.
RIVERSIDE, Calif. – Chemists at the University of California, Riverside have developed tiny, nanoscale-size rods of iron oxide particles in the lab that respond to an external magnetic field in a way that could dramatically improve how visual information ...
NJIT prof offers new desalination process using carbon nanotubes
2011-03-15
A faster, better and cheaper desalination process enhanced by carbon nanotubes has been developed by NJIT Professor Somenath Mitra. The process creates a unique new architecture for the membrane distillation process by immobilizing carbon nanotubes in the membrane pores. Conventional approaches to desalination are thermal distillation and reverse osmosis.
"Unfortunately the current membrane distillation method is too expensive for use in countries and municipalities that need potable water," said Mitra. "Generally only industry, where waste heat is freely available, ...
Guided care reduces the use of health services by chronically ill older adults
2011-03-15
A new report shows that older people who receive Guided Care, a new form of primary care, use fewer expensive health services compared to older people who receive regular primary care. Research published in the March 2011 edition of Archives of Internal Medicine found that after 20 months of a randomized controlled trial, Guided Care patients experienced, on average, 30 percent fewer home health care episodes, 21 percent fewer hospital readmissions, 16 percent fewer skilled nursing facility days, and 8 percent fewer skilled nursing facility admissions. Only the reduction ...
Antioxidants in pregnancy prevent obesity in animal offspring
2011-03-15
New biological research may be relevant to the effects of a mother's high-fat diet during pregnancy on the development of obesity in her children.
An animal study at The Children's Hospital of Philadelphia suggests that a high-fat, high-carbohydrate diet causes oxidative stress -- an excess of deleterious free radicals -- during pregnancy, predisposing the offspring to obesity and diabetes. Feeding rats antioxidants before and during pregnancy completely prevented obesity and glucose intolerance in their offspring.
If the results in animals prove to be similar ...